Initially recognized for its involvement in immune surveillance through cytotoxic lymphocyte-mediated apoptosis, GzmB has extended its influence into several realms, including autoimmune diseases, inflammatory disorders, neurological disorders, cancer immunotherapies, and allogeneic hematopoietic cell transplantation. The gene discussed is GZMB; the disease is autoimmune disease.